Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
about
sameAs
Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophagesTargeting RNA polymerase primary σ70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acidAminoglycoside modifying enzymes.Bacterial antisense RNAs: how many are there, and what are they doing?Internalization of Locked Nucleic Acids/DNA Hybrid Oligomers into Escherichia coli.Co-blockade of mecR1/blaR1 signal pathway to restore antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus.Inhibition of AAC(6')-Ib-mediated resistance to amikacin in Acinetobacter baumannii by an antisense peptide-conjugated 2',4'-bridged nucleic acid-NC-DNA hybrid oligomer.The Antisense RNA Approach: a New Application for In Vivo Investigation of the Stress Response of Oenococcus oeni, a Wine-Associated Lactic Acid Bacterium.Bridging the gap between theory and experiment to derive a detailed understanding of hammerhead ribozyme catalysis.Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens.Targeting listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids.Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecAInhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteriaPeptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages.Bacterial cellular engineering by genome editing and gene silencingPutative Inv is essential for basolateral invasion of Caco-2 cells and acts synergistically with OmpA to affect in vitro and in vivo virulence of Cronobacter sakazakii ATCC 29544.Genome engineering and gene expression control for bacterial strain development.The mycobacterial DNA-binding protein 1 (MDP1) from Mycobacterium bovis BCG influences various growth characteristicsBolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.Electroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria.Natural antisense RNAs as mRNA regulatory elements in bacteria: a review on function and applications.Translational Inhibition of CTX-M Extended Spectrum β-Lactamase in Clinical Strains of Escherichia coli by Synthetic Antisense Oligonucleotides Partially Restores Sensitivity to Cefotaxime.Evaluation of the electron transfer flavoprotein (ETF) as an antibacterial target in Burkholderia cenocepacia.The mazEF toxin-antitoxin system as an attractive target in clinical isolates of Enterococcus faecium and Enterococcus faecalis.Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide.Targeting essential genes in Salmonella enterica serovar typhimurium with antisense peptide nucleic acidVitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells.Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.Exploration of Using Antisense Peptide Nucleic Acid (PNA)-cell Penetrating Peptide (CPP) as a Novel Bactericide against Fire Blight Pathogen Erwinia amylovora.Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.Advances in therapeutic bacterial antisense biotechnology.Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids.Amikacin: Uses, Resistance, and Prospects for Inhibition.Synergetic improvements of sensitivity and specificity of nanowire field effect transistor gene chip by designing neutralized DNA as probe
P2860
Q26796753-16DC885E-6E95-48D8-B65E-2A8C5E62447BQ28478754-50FE5ED6-9DCD-4BAD-9520-ACE772AC4630Q34354185-933423B8-4BB9-4DD7-9B17-F5343961DC42Q34537427-862EAD5F-32CE-4A52-8A60-CAAA27167052Q34628844-A44F3F40-FC8D-4363-B8B6-A6D6256A4B17Q35674145-2F12B48A-C48C-451F-8A1A-A59B99B37C0EQ35960810-852FF0BD-A34C-42BA-9039-E998F854140FQ36434154-AC9DF345-A5A7-4A31-8839-EEB8DFDCCFDDQ36561838-B49E5AB5-E62C-424D-8E59-DC71B029041FQ36565579-34BF4025-F019-4690-8080-EE5B9C9123C3Q37139639-280F1539-BA29-411D-A572-DE5F5DC1FE22Q37247766-9E0271B1-2ED5-47F9-9B64-BFF118E92020Q37304179-21718753-825F-45F8-AE51-A355039FCED1Q37327293-BD761B07-2689-48C2-AC7B-26B06ACF1195Q37645309-A62A4A10-82B8-4CB9-BF39-EF9BFC21DFBEQ37713402-BA444FD7-EF40-4466-97DB-969FB4758B7EQ38243092-37109420-FE25-44E0-8D70-50D98907613BQ38290192-0205A402-CFE6-4C3C-8D68-2B4B103EDD2BQ38291228-705BAEA7-3697-4A28-8A93-661081B51BE4Q38962523-D2E4C38F-02F8-4F65-B282-126E230A8719Q39325488-38C106D3-2F20-429A-BDDA-A08C738A7724Q39428132-5E8D8133-E7CD-49A1-A6C3-8C77BDA8E82DQ40089786-93ED8AD4-BABC-462A-A07C-5A4A8548E98DQ40568030-3FF8D13C-E356-4BAB-9160-CA5598FFA3E5Q40607628-30062E66-75AB-4101-A16F-A9365C2D23E4Q41183612-CA29AA52-37A4-4E39-8F71-0516DA66EB44Q41331791-7615C482-9D2B-4CBB-BD9F-9648CC969DC5Q41487568-3A0B34EF-3B27-4A07-AA1F-0B0E369E6B19Q41780753-055961CE-CD29-4A67-88CF-58D050A7AF29Q44382639-B7754D1D-3010-43B8-9000-EE59E0C44A34Q47325247-4331F42E-1E27-4936-96DA-99CFE84AE495Q51064638-45123022-84AB-4F03-AF2A-6BFE1E8CEB8AQ52744431-065F51C1-D84B-41EE-BF11-4C60631DCA50Q58721477-ACDDB90A-4429-4EFE-B65D-283CFF2BD22E
P2860
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@ast
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@en
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@nl
type
label
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@ast
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@en
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@nl
prefLabel
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@ast
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@en
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@nl
P2093
P2860
P3181
P356
P1476
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
@en
P2093
Hans Uffe Sperling-Petersen
Kim Kusk Mortensen
Louise Carøe Vohlander Rasmussen
P2860
P2888
P3181
P356
10.1186/1475-2859-6-24
P407
P577
2007-08-10T00:00:00Z
P5875
P6179
1025771765